Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06009861 |
|---|---|
| Brief Title: | Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT) |
| First Submitted : | August 16, 2023 |
| First Submitted that Met QC Criteria : | August 22, 2023 |
| First Posted : | August 24, 2023 |
| Last Update Submitted that Met QC Criteria : | August 22, 2023 |
| Last Update Posted : | August 24, 2023 |